Mostly Markets
Stocks/Financials/Financial Exchanges & Data

CME GroupCME

Financial Exchanges & Data · Chicago, Illinois · In the S&P 500
High qualityPricier than peers
$303.14+2.27%After hours: $303.14 (0.00%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 15.9% over 1 year
CME Group over 1 yearDaily close, $, to 30 Oct 2026
$250Nov2026MarMayJulSep$303.14$250NovMarJul$303.14
Source: Nasdaq daily closes
Market value$109B
Price to earnings24.8x
Forward P/E24.0x
Dividend yield1.72%
Year to date+11.0%
One year+15.9%
Next earningsNot scheduled
52-week range (closes)
$218.58$326.46

Quality and valuation

How CME Group compares with other financials stocks. A description, not a recommendation.

CME Group and 7 financial exchanges & data peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: stronger than mostValuation: pricier than most

A stronger business than most financials companies, priced above most of them.

CME Group trades at 24.0 times the next 12 months of expected earnings, against a median of 13.0x for the 84 financials stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew slower than the sector median: +9.0% vs +10.2%
  • More profitable (operating margin): 65.7% vs 22.3%
  • Turns more of its sales into cash: 62.1% vs 20.3%
CME trades at 24.0x forward earnings, above the sector medianForward p/e, Financial Exchanges & Data peers
FDS16.8xCBOE23.4xCME24.0xNDAQ24.3xSPGI24.9xMCO28.0xMSCI29.7xCOIN143.2xSector median 13.0xFDS16.8xCBOE23.4xCME24.0xNDAQ24.3xSPGI24.9xMCO28.0xMSCI29.7xCOIN143.2xSector median 13.0x
Source: CNBC quotes; Mostly Markets
At 24.9x earnings, CME is cheaper than its average since Nov 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
20x30xAverage 25.6x2025202624.9x20x30xAverage 25.6x2025202624.9x
Source: Nasdaq prices; SEC filings

Financials

From CME Group's SEC filings, through the quarter ending 30 Sep 2026. Hover or tap a bar for its value.

Revenue grew 13.0% from a year earlierQuarterly revenue, $bn, latest Q3 ’26
$0.0bn$0.5bn$1.0bn$1.5bnQ4 ’24Q2 ’25Q4 ’25$1.7bnQ3 ’26$0bn$1bnQ4 ’24Q2 ’25Q4 ’25$1.7bnQ3 ’26
Source: SEC filings
Growth sped up to +13.0% last quarterRevenue growth, year on year, %
0%5%10%Q4 ’24Q2 ’25Q4 ’2513.0%Q3 ’260%10%Q4 ’24Q2 ’25Q4 ’2513.0%Q3 ’26
Source: SEC filings
Operating margin was 65.7% last quarterOperating income as a share of revenue, %
0%20%40%60%Q4 ’24Q2 ’25Q4 ’2565.7%Q3 ’260%25%50%Q4 ’24Q2 ’25Q4 ’2565.7%Q3 ’26
Source: SEC filings
Free cash flow was $4.3 billion over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $bn
$0.0bn$0.5bn$1.0bnQ4 ’24Q2 ’25Q4 ’25$1.1bnQ3 ’26$0.0bn$0.5bn$1.0bnQ4 ’24Q2 ’25Q4 ’25$1.1bnQ3 ’26
Source: SEC filings
Last 12 monthsCMESector median
Revenue growth+9.0%+10.2%
Operating margin65.7%22.3%
Free cash flow margin62.1%20.3%
Price to earnings24.8x14.6x

Stories on CME Group

We haven't written about CME Group yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Financial Exchanges & Data, by market value.

CompanyPriceTodayYTDValue
SPGIS&P Global$466.55+1.28%−9.0%$135B
MCOMoody's$493.91+1.04%−3.3%$85.15B
NDAQNasdaq$106.23+0.60%+9.4%$58.95B
MSCIMSCI$623.38+0.78%+8.7%$44.57B
COINCoinbase$143.54−10.62%−36.5%$37.87B
CBOECboe Global Markets$335.53+6.77%+33.7%$35.04B
FDSFactSet$329.57+2.98%+13.6%$11.62B
ICEIntercontinental Exchange––+4.3%–